"Spotlight on Pharmacists" with Amanda Cass, PharmD, BCPS, BCOP
Manage episode 521720454 series 3426844
ABOUT THIS EPISODE
Who is a pharmacist, and how are they involved in the care of neuroendocrine cancer patients? In this episode, Dr. Amanda Cass, a clinical pharmacist in the Thoracic Oncology Clinic at Vanderbilt Medical Center, explains the unique role pharmacists play—why they’re sometimes called “doctor,” how they support patients starting treatments such as cabozantinib and CAPTEM, and practical tips for staying organized, managing side effects, and navigating medication costs.
TOP TEN QUESTIONS
Getting to Know the Pharmacist
1. What exactly does a pharmacist do, and what training do they go through?
2. Why are pharmacists sometimes called “doctor,” and how is that different from a physician?
3. What role does a pharmacist play on the cancer care team?
4. How are pharmacists involved in caring for neuroendocrine cancer patients—both directly and behind the scenes?
How Pharmacists Support Treatment
5. How can a pharmacist help when someone is starting a new treatment for neuroendocrine cancer? Walk us through an example with Cabozantinib: how do you guide patients in understanding it, taking it, and managing side effects?
6. Walk us through another example with CAPTEM (capecitabine and temozolomide): how do you guide patients in understanding it, taking it, and managing side effects?
Practical Tips for Patients
7. What are some simple ways to stay organized—like keeping a medication list or symptom journal?
8. What practical tips do you share with patients about tracking and managing side effects at home?
Access and Communication
9. Who can patients talk to about medication costs or financial assistance?
10. How does someone find a pharmacist to talk to—and is it important to find one with neuroendocrine cancer experience?
ABOUT AMANDA CASS
Dr. Cass is a clinical pharmacist in the Thoracic Oncology Clinic at Vanderbilt University Medical Center. She received her Doctorate of Pharmacy from the University of Kentucky College of Pharmacy in 2016 and subsequently completed her Pharmacy Practice Residency at Grady Health System and became a Board Certified Pharmacotherapy Specialist in 2017. In 2018, she completed her Oncology Pharmacy Residency at the University of North Carolina Medical Center.
Dr. Cass's previous research interests included opioid use in non-metastatic cancer patients after curative treatment and albumin effects on oxaliplatin related toxicities. Her current areas of interest are molecular mutations and use of targeted therapies in NSCLC, immunotherapy in SCLC, and global oncology care.
Dr. Cass is the preceptor for the Outpatient Thoracic Oncology Rotation.
For more information, visit NCF.net/podcast/50
For more information, visit NCF.net.
52 פרקים